Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease

Vaso-occlusive crisis (VOC) is the primary cause of morbidity and hospitalization in sickle cell disease (SCD); however, only 4 therapies (hydroxyurea, l-glutamine, crizanlizumab, and voxeletor) are currently approved in SCD. These agents limit the duration, severity, and frequency of crises. Activa...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Blood
मुख्य लेखकों: Sparkenbaugh, Erica M., Chen, Chunsheng, Brzoska, Tomasz, Nguyen, Julia, Wang, Shaobin, Vercellotti, Gregory M., Key, Nigel S., Sundd, Prithu, Belcher, John D., Pawlinski, Rafal
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society of Hematology 2020
विषय:
Red Cells, Iron, and Erythropoiesis
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225686/
https://ncbi.nlm.nih.gov/pubmed/31977004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019003543
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन